As smog engulfs the street, essential pills for a healthy of portfolio: 5 pharma stocks with an upside potential of up to 39%

Here’s a lesson from history: For a long-term investor, buying in a correcting market is mostly an opportunity. The operative part, of course, is “long-term investor” – not people who check the value of their portfolio every evening. Also, focus on a sector that is making a comeback. Why? Because when a sector catches the limelight for the first time, valuations are high – and promoters tend to be more optimistic than realistic. In a sector that has gone through a troubled phase and is making a comeback, promoters have learnt their lessons and are more realistic in their expectations – as also in capital allocation. Pharma is one such sector. And there are more reasons to take a closer look at it.